Back to Authors

Krankel, Cynthia

Mayo Clinic

Dana-Farber Cancer Institute

Citations 1

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
Milne, Thomas A. , Hughes, Christina M., Lloyd, Ricardo V., Rozenblatt–Rosen, Orit , Schnepp, Robert W. , Krankel, Cynthia, LiVolsi, Virginia A. , Gibbs, Denise , Hua, Xianxin , Hess, Jay L. , Yang, Zhaohai , Dou, Yali , Roeder, Robert G. , Meyerson, Matthew

Proceedings of the National Academy of Sciences | January 7, 2005 | Volume: 102 | Issue: 3 | Pages: 749-754

10.1073/pnas.0408836102 Get It

Mutations in the MEN1 gene are associated with the multiple endocrine neoplasia syndrome type 1 (MEN1), which is characterized by parathyroid hyperplasia and tumors of the pituitary and pancreatic islets. The mechanism by which MEN1 acts as a tumor suppressor is unclear. We have recently shown that menin, the MEN1 protein product, interacts with mixed lineage leukemia (MLL) family proteins in a histone methyltransferase complex including Ash2, Rbbp5, and WDR5. Here, we show that menin directly regulates expression of the cyclin-dependent kinase inhibitors p27 Kip1 and p18 Ink4c . Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27 Kip1 and p18 Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27 Kip1 and p18 Ink4c expression and deregulated cell growth. These findings suggest that regulation of cyclin-dependent kinase inhibitor transcription by cooperative interaction between menin and MLL plays a central role in menin's activity as a tumor suppressor.